Cart
sales@molnova.com
Home - Products - Others - Other Targets - 1-[(3-Methoxy-8-hydroxy-1-O-β-D-gentiobioside)-6-YL]propan-2-one

1-[(3-Methoxy-8-hydroxy-1-O-β-D-gentiobioside)-6-YL]propan-2-one

CAS No. 2435563-23-6

1-[(3-Methoxy-8-hydroxy-1-O-β-D-gentiobioside)-6-YL]propan-2-one( ——— )

Catalog No. M39038 CAS No. 2435563-23-6

1-[(3-Methoxy-8-hydroxy-1-O-β-D-gentiobioside)-6-YL]propan-2-one

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    1-[(3-Methoxy-8-hydroxy-1-O-β-D-gentiobioside)-6-YL]propan-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    1-[(3-Methoxy-8-hydroxy-1-O-β-D-gentiobioside)-6-YL]propan-2-one
  • Description
    1-[(3-Methoxy-8-hydroxy-1-O-β-D-gentiobioside)-6-YL]propan-2-one
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    2435563-23-6
  • Formula Weight
    570.54
  • Molecular Formula
    C26H34O14
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • BMS-593214

    BMS-593214 is an active site-directed factor (F) VIIa inhibitor that exhibits antithrombotic and antihaemostatic properties.

  • Cy 3

    Cy 3 is a fluorescent label for protein and nucleic acid.

  • L-allo-Isoleucine

    L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.

Sign In Join Free